New hope for Tough-to-Treat breast cancer? trial tests novel drug
NCT ID NCT04059484
Summary
This study tested whether a new oral drug called amcenestrant could better control advanced breast cancer compared to standard hormone therapy. It involved 367 adults whose cancer had worsened despite prior hormone treatments. The goal was to see if the new drug could delay cancer growth longer and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Birmingham, Alabama, 35205, United States
-
Associacao de Combate ao Cancer em Goias Hospital Araujo Jorge- Site Number : 0760005
Goiânia, Goiás, 74605-070, Brazil
-
Comprehensive Blood and Cancer Center Site Number : 8400018
Bakersfield, California, 93309, United States
-
Dana-Farber Cancer Institute- Site Number : 8400015
Boston, Massachusetts, 02215, United States
-
Dartmouth-Hitchcock Medical Center - Lebanon - 1 Medical Center Drive- Site Number : 8400013
Lebanon, New Hampshire, 03756, United States
-
Fundação Faculdade Regional de Medicina de São José do Rio Preto- Site Number : 0760003
São José do Rio Preto, São Paulo, 15090-000, Brazil
-
Gabrail Cancer Center- Site Number : 8400006
Canton, Ohio, 44718, United States
-
Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400025
Hackensack, New Jersey, 07601, United States
-
Hematology Oncology Clinic Site Number : 8400020
Baton Rouge, Louisiana, 70809, United States
-
Hospital Auxilio Mutuo- Site Number : 8400028
San Juan, 00918, Puerto Rico
-
Hospital Mae de Deus Site Number : 0760002
Porto Alegre, Rio Grande do Sul, 90880-480, Brazil
-
Hospital de Clinicas de Porto Alegre- Site Number : 0760001
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
-
IBCC - Núcleo de Pesquisa e Ensino- Site Number : 0760006
São Paulo, 04014-002, Brazil
-
Investigational Site Number : 0320001
Buenos Aires, 1426, Argentina
-
Investigational Site Number : 0320002
Salta, 4400, Argentina
-
Investigational Site Number : 0320004
La Rioja, 5300, Argentina
-
Investigational Site Number : 0320005
Rosario, Santa Fe Province, 2000, Argentina
-
Investigational Site Number : 0320006
Buenos Aires, 1125, Argentina
-
Investigational Site Number : 0320007
Buenos Aires, 1012, Argentina
-
Investigational Site Number : 0320008
Buenos Aires, 1019, Argentina
-
Investigational Site Number : 0360001
Nedlands, Western Australia, 6009, Australia
-
Investigational Site Number : 0360002
Woolloongabba, Queensland, 4102, Australia
-
Investigational Site Number : 0360003
South Brisbane, Queensland, 4101, Australia
-
Investigational Site Number : 0560001
Leuven, 3000, Belgium
-
Investigational Site Number : 0560002
Charleroi, 6000, Belgium
-
Investigational Site Number : 0560003
Namur, 5000, Belgium
-
Investigational Site Number : 1240003
London, Ontario, N6A 5W9, Canada
-
Investigational Site Number : 1240004
Calgary, Alberta, T2N 4N2, Canada
-
Investigational Site Number : 1240006
Montreal, Quebec, H3T 1E2, Canada
-
Investigational Site Number : 1560001
Beijing, 100021, China
-
Investigational Site Number : 1560002
Hangzhou, 310022, China
-
Investigational Site Number : 1560003
Kunming, Michigan, 650106, China
-
Investigational Site Number : 1560005
Harbin, 150081, China
-
Investigational Site Number : 1560008
Linyi, 276000, China
-
Investigational Site Number : 1560010
Hefei, 230001, China
-
Investigational Site Number : 1560011
Nanjing, 210029, China
-
Investigational Site Number : 1560013
Tianjin, 300060, China
-
Investigational Site Number : 1560014
Changsha, 410005, China
-
Investigational Site Number : 1560015
Changchun, 130021, China
-
Investigational Site Number : 1560016
Wuhan, 430079, China
-
Investigational Site Number : 1560018
Hefei, 230022, China
-
Investigational Site Number : 1560021
Ürümqi, 830000, China
-
Investigational Site Number : 1560023
Hangzhou, 310016, China
-
Investigational Site Number : 1560024
Chongqing, Maryland, 400030, China
-
Investigational Site Number : 1560025
Chengdu, 610041, China
-
Investigational Site Number : 1560026
Jinan, 250013, China
-
Investigational Site Number : 1560031
Xuzhou, 221018, China
-
Investigational Site Number : 1580001
Taipei, 100, Taiwan
-
Investigational Site Number : 1580002
Taichung, 404, Taiwan
-
Investigational Site Number : 1580003
Tainan, 704, Taiwan
-
Investigational Site Number : 1580004
Taipei, 114, Taiwan
-
Investigational Site Number : 1580005
Taipei, 104, Taiwan
-
Investigational Site Number : 2030002
Brno, 656 53, Czechia
-
Investigational Site Number : 2030003
Nový Jičín, 741 01, Czechia
-
Investigational Site Number : 2030004
Prague, 140 59, Czechia
-
Investigational Site Number : 2500001
Villejuif, 94805, France
-
Investigational Site Number : 2500005
Paris, 75010, France
-
Investigational Site Number : 2500006
Créteil, 94010, France
-
Investigational Site Number : 2500007
Marseille, 13273, France
-
Investigational Site Number : 2500008
Angers, 49055, France
-
Investigational Site Number : 3000001
Heraklion, 711 10, Greece
-
Investigational Site Number : 3000002
Larissa, 411 10, Greece
-
Investigational Site Number : 3000004
Thessaloniki, Quebec, 546 45, Greece
-
Investigational Site Number : 3760001
Petah Tikva, 4941492, Israel
-
Investigational Site Number : 3760002
Jerusalem, 9103102, Israel
-
Investigational Site Number : 3760003
Tel Aviv, 6423906, Israel
-
Investigational Site Number : 3760004
Ramat Gan, 5262100, Israel
-
Investigational Site Number : 3800001
Candiolo, Torino, 10060, Italy
-
Investigational Site Number : 3800002
Milan, Milano, 20141, Italy
-
Investigational Site Number : 3800003
Prato, 59100, Italy
-
Investigational Site Number : 3920001
Kashiwa, Chiba, 277-8577, Japan
-
Investigational Site Number : 3920002
Nagoya, Aichi-ken, 464-8681, Japan
-
Investigational Site Number : 3920003
Osaka, 540-0006, Japan
-
Investigational Site Number : 3920004
Chūō, Tokyo, 104-0045, Japan
-
Investigational Site Number : 3920005
Ina, Nagano, 362-0806, Japan
-
Investigational Site Number : 3920006
Yokohama, Kanagawa, 241-0815, Japan
-
Investigational Site Number : 3920008
Tokyo, 135-8550, Japan
-
Investigational Site Number : 3920009
Ōta, Gunma, 373-8550, Japan
-
Investigational Site Number : 4100001
Seoul, Seoul-teukbyeolsi, 03080, South Korea
-
Investigational Site Number : 4100002
Seoul, Seoul-teukbyeolsi, 06351, South Korea
-
Investigational Site Number : 4100003
Seoul, Seoul-teukbyeolsi, 05505, South Korea
-
Investigational Site Number : 4100004
Seoul, Seoul-teukbyeolsi, 03722, South Korea
-
Investigational Site Number : 4280001
Riga, LV-1038, Latvia
-
Investigational Site Number : 4280002
Riga, LV-1002, Latvia
-
Investigational Site Number : 4840002
Monterrey, Nuevo León, 64460, Mexico
-
Investigational Site Number : 4840005
Mexico City, 03100, Mexico
-
Investigational Site Number : 4840006
Veracruz, 91900, Mexico
-
Investigational Site Number : 6160001
Warsaw, Masovian Voivodeship, 02-781, Poland
-
Investigational Site Number : 6160003
Poznan, Greater Poland Voivodeship, 61-866, Poland
-
Investigational Site Number : 6430002
Saint Petersburg, Georgia, 197758, Russia
-
Investigational Site Number : 6430003
Moscow, 115478, Russia
-
Investigational Site Number : 6430005
Moscow, 105005, Russia
-
Investigational Site Number : 7240001
L'Hospitalet de Llobregat, Catalunya [Cataluña], 08907, Spain
-
Investigational Site Number : 7240003
Barcelona, Catalunya [Cataluña], 08036, Spain
-
Investigational Site Number : 7240006
Barcelona, Barcelona [Barcelona], 08035, Spain
-
Investigational Site Number : 7240008
Málaga, 29010, Spain
-
Investigational Site Number : 7920002
Edirne, 22030, Turkey (Türkiye)
-
Investigational Site Number : 7920003
Istanbul, 34722, Turkey (Türkiye)
-
Investigational Site Number : 7920004
Ankara, 06200, Turkey (Türkiye)
-
Investigational Site Number : 8040001
Kryvyi Rih, 50048, Ukraine
-
Investigational Site Number : 8040004
Odesa, 65025, Ukraine
-
Investigational Site Number : 8040005
Uzhhorod, 88000, Ukraine
-
Northwest Medical Specialties Tacoma- Site Number : 8400038
Tacoma, Washington, 98405, United States
-
Saint Luke's Hospital of Kansas City- Site Number : 8400032
Kansas City, Missouri, 64111, United States
-
The Center for Cancer & Blood Disorders - Fort Worth- Site Number : 8400022
Fort Worth, Texas, 76104, United States
-
UCLA Santa Monica - Parkside- Site Number : 8400024
Santa Monica, California, 90404, United States
-
University of Kansas Clinical Research Center- Site Number : 8400027
Fairway, Kansas, 66205, United States
-
University of Vermont Medical Center- Site Number : 8400026
Burlington, Vermont, 05401, United States
-
University of Wisconsin Hospitals and Clinics- Site Number : 8400016
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.